Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AZN
GILD
Add up to 3 more stocks
AZN
AstraZeneca PLC
+0.33%
$160.17+0.53Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$248.40B
52W Range
$145.80 - $212.71
GILD
Gilead Sciences, Inc.
-0.75%
$143.72-1.09Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$178.44B
52W Range
$108.46 - $157.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 24.05 | N/A |
| Forward P/E | 15.64 | N/A |
| P/B Ratio | 4.94 | 15.09 |
| P/S Ratio | 4.05 | 5.86 |
| P/FCF Ratio | 28.42 | 13.76 |
| EV/EBITDA | 13.56 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 81.9% | 79.6% |
| Operating Margin | 22.8% | 39.7% |
| Net Margin | 17.0% | -10.6% |
| ROE | 20.8% | -27.4% |
| ROA | 9.0% | -6.6% |
| ROIC | 12.8% | -3.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.89 | 1.27 |
| Quick Ratio | 0.67 | 1.09 |
| Debt/Equity | 0.64 | 2.22 |
| Interest Coverage | 8.11 | 11.43 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.0% | 2.2% |
| Payout Ratio | 48.5% | N/A |
| Yrs of Dividend Growth | 2 | 10 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.